FDA — authorised 20 December 1985
- Application: NDA018654
- Marketing authorisation holder: HLR
- Local brand name: VERSED
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Midazolam demand in United States
FDA authorised Midazolam demand on 20 December 1985
Marketing authorisations
FDA — authorised 15 October 1998
- Application: NDA020942
- Marketing authorisation holder: ROCHE
- Local brand name: VERSED
- Indication: SYRUP — ORAL
- Status: approved
FDA
- Status: approved
Midazolam demand in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Midazolam demand approved in United States?
Yes. FDA authorised it on 20 December 1985; FDA authorised it on 15 October 1998; FDA has authorised it.
Who is the marketing authorisation holder for Midazolam demand in United States?
HLR holds the US marketing authorisation.